GoKawiilAbbott wins FDA clearance for Libre Duo, a combined glucose-ketone monitor
Abbott has received FDA authorization for the Libre Duo, its first continuous glucose monitor that tracks both blood glucose and ketone levels in a single wearable sensor. The device requires a prescription and lasts 10 days, mirroring the design of Abbott's existing Libre CGM lineup but adding ketone detection aimed at catching dangerous spikes before they turn into ketoacidosis.